Current approaches to the use of artificial sweetener aspartame

Authors

  • Fatma Gönül Solmaz Department of Biology, Faculty of Science & Arts, Ondokuz Mayıs University, Samsun, Turkey.
  • Emine Dıraman Department of Biology, Faculty of Science & Arts, Ondokuz Mayıs University, Samsun, Turkey.
  • Birol Sezgin Department of Biology, Faculty of Science & Arts, Ondokuz Mayıs University, Samsun, Turkey.

DOI:

https://doi.org/10.30574/gscbps.2021.14.3.0044

Keywords:

Aspartame, Sweetener, Artificial, Dose

Abstract

With the recommendation of the World Health Organization (WHO) to reduce the sugar consumption of children and adults to less than 10% of the total energy intake, many people turned to sweeteners. Aspartame (E951), an artificial sweetener, is synthesized from L-phenylalanine or methyl ester of L-phenylalanine with L-aspartic acid. It is an amphoteric dipeptide composed of aspartic acid and phenylalanine. Apart from chemical peptide synthesis, aspartame can also be synthesized enzymatically commercially. 1 gr of it gives 4 Kcal energy. The taste perception of aspartame appears delayed and lasts a long time. Since it is not heat resistant during cooking, it can only be used as a sweetener in cold drinks and food, coffee, tea. Although there were some scientific objections after the introduction of aspartame to the market, animal and human experiments and investigations started to increase. In another study; Consumption of 40, 75, 500 mg/kg/day aspartame have increased oxidative stress parameters and has been reported to damage liver antioxidant capacity. Also, in some other studies in which negative effects on experimental animals were discussed, 250, 500, 1000 mg/kg/day aspartame consumption was found to significantly increase the liver enzymes alanine aminotransferase (ALT) and aspartate aminotransferase (AST). Besides, studies showing that aspartame does not have negative effects on health, 240 mg/kg/day aspartame consumption did not make a significant difference in alanine aminotransferase (ALT) value, and there was no significant difference between the groups in fasting blood glucose with 4% aspartame solution daily consumption. On the other hand, studies on aspartame toxicity also have conflicting results. Some studies using in vivo and in vitro tests have shown that aspartame does not cause genotoxicity, DNA damage, and mutagenesis, but does stimulate chromosome aberrations and micronucleus formation. Many studies have been done to show the safety of aspartame. The European Food Safety Authority stated in its 2013 re-evaluation that aspartame is safe for human consumption at current exposure levels. In a review evaluating the data obtained from aspartame studies, it is supported that aspartame is a safe sweetener when used within the recommended dose limits. For aspartame, this value (ADI) has been recommended as 40 mg/kg body weight/day.

Considering its association with age, gender, personal metabolism, and metabolic diseases, it was concluded that the use of aspartame is safe, with the fact that it has some harmful effects depending on the exposure time and dose.

Metrics

Metrics Loading ...

References

Ahmad SY, Friel J, Mackay D. The Effects of Non-Nutritive Artificial Sweeteners, Aspartame and Sucralose, on the Gut Microbiome in Healthy Adults: Secondary Outcomes of a Randomized Double-Blinded Crossover Clinical Trial. Nutrients. 2020; 12: 34-08.

Altuğ T, Elmacı Y. Food additives. Sweeteners (T. Altuğ editor) Meta Press, İzmir, Turkey. 2001; 286s.

Andreatta MM, Muñoz SE, Lantieri MJ, et al. Artificial sweetener consumption and urinary tract tumors in Cordoba, Argentina. Prev Med. 2008; 47: 136-139.

Ashok I, Wankhar D, Sheeladevi R, Wankhar W. Long-term effect of aspartame on the liver antioxidant status and histopathology in Wistar albino rats. Biomedicine & Preventive Nutrition. 2014; 4(2): 299-305.

Butchko HH, Stargel WW, Comer PC, Mayhew DA, et al. Aspartame: Review of safety. Regul Toxicol Pharmacol. 2002; 35: S1-S93.

Butchko HH, Stargel WW. Aspartame:Scientific evaluation in the postmarketing period. Regul Toxicol Pharmacol. 2001; 34: 221-33.

Doğan M, Boroğlu E. Aspartame E 951 in Dairy Industry. Milk Microbiology Additives. VI. Milk and Dairy Products Symposium. 2000.

Guy RC. Aspartame. Encyclopedia of Toxicology (Third Edition). 2014.

Iman MM. Effect of aspartame on some oxidative stress parameters in liver and kidney of rats. African Journal of Pharmacy and Pharmacology. 2011; 5(6): 678-682.

İşgören Aynur, Sungur Sıdıka. Sweeteners. Lectio Scientific Journal of Health and Natural Sciences. July 2011; 3(1): 19-32.

Kanietha Priya AS, Ganesh Prasath S. Comparison of effect of aspartame (artificial sweetener) and aspartamesweetened diet drink on autonomic reactivity of volunteers. National Journal of Physiology, Pharmacy and Pharmacology. 2018; 8(7): 1057-1060.

Magnuson BA, Burdock GA, Doull J, Kroes RM, Marsh GM,et.al. Aspartame: A safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies. Critical Reviews in Toxicology. 2008; 3: 629-727.

Nampoothiri, K. Madhavan, Gopinatha Vipin, Anusree M, Gopalan Nishant, Dhar Kiran S. Bioenergy Research: Advances and Applications. 2014; 337-352.

Nehrling J, Kobe P, Mclane P, Mclane BS, Ronald EO, Kamath S, David L, Horwitz MD. Aspartame use by persons with diabetes. American Diabetes Association. 2015.

Otman S, Bin-Jumah M. Histopathological Effect of Aspartame on Liver and Kidney of Mice. International Journal of Pharmacology. 2019; 15(3): 336- 342.

Öz, Şerife Gül. Argument on the Safety of Aspartame. Journal of Ankara University Medicine Faculty. 2003; 56(2).

Özturan A, Şanlıer N, Coşkun Ö. The Relationship between Migraine and Nutrition. Turk J Neurol. 2016; 22: 44-50.

Palmnäs MS, Cowan TE, Bomhof MR, Su J, Reimer RA, Vogel HJ, Hittle DS, Shearer J. Low-dose aspartame consumption differentially affects gut microbiota-host metabolic interactions in the diet-induced obese rat. PloS one. 2014; 9(10): 1-10.

Pehlivan M, Köksal E. Effects of natural and artificial sweeteners on glucose intolerance, liver enzymes and oxidative stress. Mersin University Journal of Health Sciences. 2020; 13(1): 140-154.

Polat F, Dere E, Arı F, Turaçlar N, Bingöl G, Aztopal N. Effect of Aspartame on Acetylcholinesterase Activity in Some of Rat Tissues. Hacettepe J. Biol. & Chem. 2017; 45(3): 321–327.

Ranney RE, Oppermann JA, Muldoon E, McMahon FG. Toxicol Environ Healthn. 1976; 2(2): 441-51.

Rowe RC. Aspartame. Handbook of Pharmaceutical Excipients. 2009; 11–12.

Spiers PA, Sabaounjian L, Reiner A, Myers DK, et.al. Aspartame: Neuropsychologic and neurophysiologic evaluation of acute and chronic effects. Am J Clin Nutr. 1998; 68: 531-37.

Şen S, Aksoy H, Yılmaz S. Genotoxic, carcinogenic potential of food additives and their other effects on human health. International Journal of Human Sciences. 2017; 14(4): 3093-3108.

Tephly TR. Comments on the purported generation of formaldehyde and adduct formation from the sweetener aspartame. Life Sci. 1999; 65(13): 157-60.

Yurdagel Ü. Use of Artificial Sweeteners in Diabetic Foods. Food Technology Year. 1996; 1(8): 55 -59.

https://www.efsa.europa.eu/en/topics/topic/aspartame (16.07.2019, 11:09)

https://www.slideshare.net/10Preeti/artificial-sweeteners-32762827, (18.12.2020 10:32).

Downloads

Published

2021-03-30

How to Cite

Fatma Gönül Solmaz, Emine Dıraman, & Birol Sezgin. (2021). Current approaches to the use of artificial sweetener aspartame. GSC Biological and Pharmaceutical Sciences, 14(3), 036–041. https://doi.org/10.30574/gscbps.2021.14.3.0044

Issue

Section

Review Article